Mobile

A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splene...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000174-31

A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to evaluate the efficacy of AMG 531 in the treatment of thrombocytopenia in subjects with ITP refractory to splenectomy as measured by the durable platelet response during the last 8 weeks of treatment and other platelet response parameters.

Critère d'inclusion

  • Thrombocytopenia in subjects with Immune Thrombocytopenic Purpura (ITP)

Liens